Comparison of Borrowing Methods for Incorporating Historical Data in Single-Arm Phase II Clinical Trials.

IF 2 4区 医学 Q4 MEDICAL INFORMATICS Therapeutic innovation & regulatory science Pub Date : 2025-01-01 Epub Date: 2024-11-21 DOI:10.1007/s43441-024-00723-5
Sara Urru, Michela Verbeni, Danila Azzolina, Ileana Baldi, Paola Berchialla
{"title":"Comparison of Borrowing Methods for Incorporating Historical Data in Single-Arm Phase II Clinical Trials.","authors":"Sara Urru, Michela Verbeni, Danila Azzolina, Ileana Baldi, Paola Berchialla","doi":"10.1007/s43441-024-00723-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Over the last few years, many efforts have been made to leverage historical information in clinical trials. Incorporating historical data into current trials allows for a more efficient design, smaller studies, or shorter duration and may potentially increase the relative amount of information on efficacy and safety. Despite these advantages, it is crucial to select external data sources appropriately to avoid introducing potential bias into the new study. This is where borrowing methods become useful. We illustrate and compare the latest methods of borrowing historical data in a single-arm phase II clinical trial setting, examining their impact on statistical power and type I error.</p><p><strong>Methods: </strong>We implemented static and dynamic versions of the power prior method, incorporating overlapping coefficient and loss functions and meta-analytic predictive priors. These methods were compared with standard and pooling approaches, in which none or all historical data are used.</p><p><strong>Results: </strong>Dynamic borrowing methods achieve lower type I error inflation than pooling. The power prior approach, integrated with overlapping coefficient, allowed for measuring the similarity of the subjects considering their baseline characteristics, thus the likelihood of the data contains information about both confounders and outcome. Using a discounting function to estimate the power parameter guarantees the similarity of historical information and current trial data.</p><p><strong>Conclusion: </strong>We provided a comprehensive overview of borrowing methods, encompassing frequentist and Bayesian approaches as well as static and dynamic technique, to guide researchers in selecting the most appropriate strategy.</p>","PeriodicalId":23084,"journal":{"name":"Therapeutic innovation & regulatory science","volume":" ","pages":"20-30"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic innovation & regulatory science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s43441-024-00723-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/21 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Over the last few years, many efforts have been made to leverage historical information in clinical trials. Incorporating historical data into current trials allows for a more efficient design, smaller studies, or shorter duration and may potentially increase the relative amount of information on efficacy and safety. Despite these advantages, it is crucial to select external data sources appropriately to avoid introducing potential bias into the new study. This is where borrowing methods become useful. We illustrate and compare the latest methods of borrowing historical data in a single-arm phase II clinical trial setting, examining their impact on statistical power and type I error.

Methods: We implemented static and dynamic versions of the power prior method, incorporating overlapping coefficient and loss functions and meta-analytic predictive priors. These methods were compared with standard and pooling approaches, in which none or all historical data are used.

Results: Dynamic borrowing methods achieve lower type I error inflation than pooling. The power prior approach, integrated with overlapping coefficient, allowed for measuring the similarity of the subjects considering their baseline characteristics, thus the likelihood of the data contains information about both confounders and outcome. Using a discounting function to estimate the power parameter guarantees the similarity of historical information and current trial data.

Conclusion: We provided a comprehensive overview of borrowing methods, encompassing frequentist and Bayesian approaches as well as static and dynamic technique, to guide researchers in selecting the most appropriate strategy.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
单臂 II 期临床试验中纳入历史数据的借用方法比较。
背景:在过去几年中,人们为在临床试验中利用历史资料做出了许多努力。将历史数据纳入当前的试验可以提高设计效率、缩小研究规模或缩短持续时间,并有可能增加疗效和安全性方面的相对信息量。尽管有这些优势,但关键是要适当选择外部数据源,以避免在新研究中引入潜在偏差。这就是借鉴方法的用武之地。我们说明并比较了在单臂 II 期临床试验中借用历史数据的最新方法,考察了它们对统计能力和 I 型误差的影响:方法:我们采用了静态和动态版本的功率先验方法,其中包含了重叠系数和损失函数以及元分析预测先验。我们将这些方法与标准方法和汇集方法进行了比较,在汇集方法中,不使用或全部使用历史数据:结果:动态借用法的 I 类错误膨胀率低于集合法。功率先验方法与重叠系数相结合,可以衡量受试者基线特征的相似性,因此数据的可能性包含了混杂因素和结果的信息。使用贴现函数估算功率参数可保证历史信息与当前试验数据的相似性:我们全面概述了借用方法,包括频数法和贝叶斯法以及静态和动态技术,以指导研究人员选择最合适的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Therapeutic innovation & regulatory science
Therapeutic innovation & regulatory science MEDICAL INFORMATICS-PHARMACOLOGY & PHARMACY
CiteScore
3.40
自引率
13.30%
发文量
127
期刊介绍: Therapeutic Innovation & Regulatory Science (TIRS) is the official scientific journal of DIA that strives to advance medical product discovery, development, regulation, and use through the publication of peer-reviewed original and review articles, commentaries, and letters to the editor across the spectrum of converting biomedical science into practical solutions to advance human health. The focus areas of the journal are as follows: Biostatistics Clinical Trials Product Development and Innovation Global Perspectives Policy Regulatory Science Product Safety Special Populations
期刊最新文献
Evaluation of United Kingdom (UK)-Windsor Framework and Comparison Against European Union (EU) Regulations for Medicines Regulation. Verifying Clinical Benefit of New Anticancer Drugs After Regulatory Approval Based on Exploratory Studies. Focusing on First Cycle Approval in ANDA Submission: Understanding Common Deficiencies & Case Study Insights. Assessment of Local Pharmaceutical Manufacturing Sector in a Low-income Country: A Descriptive Study. The Ethics of the "Right-to-Try" Movement in an Era of Regulatory Flux.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1